Selecting treatment options for TKI-resistant chronic myeloid leukemia Journal Article


Author: Mauro, M. J.
Article Title: Selecting treatment options for TKI-resistant chronic myeloid leukemia
Keywords: vasculotropin; cancer survival; gene mutation; overall survival; hydroxyurea; interferon; cancer risk; drug efficacy; drug safety; skin manifestation; cytarabine; imatinib; progression free survival; bone marrow suppression; clinical assessment; dasatinib; chronic myeloid leukemia; protein tyrosine kinase inhibitor; protein synthesis; cardiovascular disease; cerebrovascular disease; bcr abl protein; cytotoxic t lymphocyte antigen 4; nilotinib; homoharringtonine; programmed death 1 receptor; pulmonary hypertension; bosutinib; peripheral occlusive artery disease; ponatinib; human; article
Journal Title: Clinical Advances in Hematology & Oncology
Volume: 12
Issue: 7 Suppl. 13
ISSN: 1543-0790
Publisher: Millennium Medical Publishing, Inc  
Date Published: 2014-07-01
Start Page: 12
End Page: 16
Language: English
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 2 October 2015 -- Source: Scopus
MSK Authors
  1. Michael John Mauro
    126 Mauro